Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/48580
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAERTS, Sofie-
dc.contributor.authorGEYS, Lotte-
dc.contributor.authorSEVERIJNS, Deborah-
dc.contributor.authorAlkhawajah, Mona-
dc.contributor.authorBerger, Thomas-
dc.contributor.authorBoyko, Alexey-
dc.contributor.authorGrigoriadis, Nikolaos-
dc.contributor.authorHartung, Hans-Peter-
dc.contributor.authorMagyari, Melinda-
dc.contributor.authorOreja-Guevara, Celia-
dc.contributor.authorPozzilli, Carlo-
dc.contributor.authorVermersch, Patrick-
dc.contributor.authorYamout, Bassem-
dc.contributor.authorZakaria, Magd-
dc.contributor.authorZiemssen, Tjalf-
dc.contributor.authorPOPESCU, Veronica-
dc.contributor.authorPEETERS, Liesbet-
dc.contributor.authorVAN WIJMEERSCH, Bart-
dc.date.accessioned2026-02-19T09:02:31Z-
dc.date.available2026-02-19T09:02:31Z-
dc.date.issued2026-
dc.date.submitted2026-02-16T16:19:52Z-
dc.identifier.citationJournal of the neurological sciences, 481 (Art N° 125756)-
dc.identifier.urihttp://hdl.handle.net/1942/48580-
dc.description.abstractBackground: Reliable prognostication in multiple sclerosis (MS) is essential for personalized care, yet remains challenging. In the absence of widely implemented prognostic tools, how MS specialists today formulate prognostic judgments and manage related challenges in routine practice is underexplored. Objective: To investigate how MS specialists approach prognostication in practice and identify their priorities for improving prognosis-informed care. Methods: Twelve MS specialists from European and Middle Eastern regions participated in semi-structured interviews. Data were qualitatively analyzed using a two-phase content analysis. Priorities were topics mentioned by more than 50% of participants. Results: Nine priority questions were identified for improving prognosis-informed MS care: 1) What minimal data are needed to estimate prognosis early?, 2) How should prognostic factors be combined and weighted?, 3) How can subclinical progression be detected and addressed?, 4) How can (less experienced) neurologists be better supported?, 5) How should prognosis-based decisions align with reimbursement and patient preferences?, 6) How can clinical intuition be used alongside evidence?, 7) How can prognosis be communicated, supporting patient optimism and empowerment?, 8) How to develop prognostic tools for MS?, 9) How can quality of life be integrated as a core prognostic outcome?. Conclusion: MS prognostication in current practice remains fragmented and experience-driven. Addressing these questions could guide future research and the development of prognostic tools that embed prognosis-informed care into MS management.-
dc.description.sponsorshipSpecial Research Fund of Hasselt University [BOF22DOC18]-
dc.language.isoen-
dc.publisherELSEVIER-
dc.subject.otherMultiple sclerosis-
dc.subject.otherPrognosis-
dc.subject.otherPrognostication-
dc.subject.otherNeurologist-
dc.subject.otherPersonalized care-
dc.subject.otherPrognostic tools-
dc.titleDirections for advancing prognostic assessments in multiple sclerosis: Qualitative Insights from MS specialist Interviews-
dc.typeJournal Contribution-
dc.identifier.volume481-
local.format.pages9-
local.bibliographicCitation.jcatA1-
dc.description.notesAerts, S (corresponding author), UHasselt, Biomed Res Inst BIOMED, Diepenbeek, Belgium.-
dc.description.notessofie.aerts@uhasselt.be-
local.publisher.placeRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS-
local.type.refereedRefereed-
local.type.specifiedArticle-
local.bibliographicCitation.artnr125756-
dc.identifier.doi10.1016/j.jns.2026.125756-
dc.identifier.pmid41570412-
dc.identifier.isi001677227600001-
local.provider.typewosris-
local.description.affiliation[Aerts, Sofie; Geys, Lotte; Severijns, Deborah; Popescu, Veronica; Peeters, Liesbet M.; Van Wijmeersch, Bart] Univ MS Ctr UMSC, Hasselt, Belgium.-
local.description.affiliation[Aerts, Sofie; Geys, Lotte; Popescu, Veronica; Peeters, Liesbet M.; Van Wijmeersch, Bart] UHasselt, Biomed Res Inst BIOMED, Diepenbeek, Belgium.-
local.description.affiliation[Aerts, Sofie; Severijns, Deborah; Popescu, Veronica; Van Wijmeersch, Bart] Rehabil & MS Ctr, Noorderhart, Pelt, Belgium.-
local.description.affiliation[Aerts, Sofie; Severijns, Deborah; Van Wijmeersch, Bart] UHasselt, Rehabil Res Ctr REVAL, Diepenbeek, Belgium.-
local.description.affiliation[Geys, Lotte; Peeters, Liesbet M.] UHasselt, Data Sci Inst DSI, Diepenbeek, Belgium.-
local.description.affiliation[Alkhawajah, Mona] KFSH &RC & Alfaisal Univ, Neurosci Ctr Excellence, Dept Neuroimmunol & Neuromuscular Dis, Sect Neuroimmunol, Riyadh, Saudi Arabia.-
local.description.affiliation[Berger, Thomas; Hartung, Hans-Peter] Med Univ Vienna, Dept Neurol, Vienna, Austria.-
local.description.affiliation[Berger, Thomas] Med Univ Vienna, Comprehens Ctr Clin Neurosci & Mental Hlth, Vienna, Austria.-
local.description.affiliation[Boyko, Alexey] Pirogov Russian Natl Res Med Univ, Moscow, Russia.-
local.description.affiliation[Boyko, Alexey] Fed Ctr Brain Res & Neurotechnol, Moscow, Russia.-
local.description.affiliation[Grigoriadis, Nikolaos] Aristotle Univ Thessaloniki, Sch Med, Dept Neurol 2, Special Unit Biomed Res & Educ SUBRE, Thessaloniki, Greece.-
local.description.affiliation[Hartung, Hans-Peter] Heinrich Heine Univ Dusseldorf, Dept Neurol, Dusseldorf, Germany.-
local.description.affiliation[Hartung, Hans-Peter] Univ Sydney, Brain & Mind Ctr, Sydney, Australia.-
local.description.affiliation[Hartung, Hans-Peter] Palacky Univ, Dept Neurol, Olomouc, Czech Republic.-
local.description.affiliation[Magyari, Melinda] Rigshospitalet, Danish Multiple Sclerosis Registry, Dept Neurol, Copenhagen, Denmark.-
local.description.affiliation[Magyari, Melinda] Rigshospitalet, Danish Multiple Sclerosis Ctr, Dept Neurol, Copenhagen, Denmark.-
local.description.affiliation[Oreja-Guevara, Celia] Hosp Clin San Carlos, Radiol Dept, IdiSSC, Madrid, Spain.-
local.description.affiliation[Oreja-Guevara, Celia] Univ Complutense Madrid UCM, Fac Med, Dept Med, Madrid, Spain.-
local.description.affiliation[Pozzilli, Carlo] Sapienza Univ, Dept Human Neurosci, Rome, Italy.-
local.description.affiliation[Vermersch, Patrick] Univ Lille, Inserm LilNCog U1172, CHU Lille, FHU Precise, Lille, France.-
local.description.affiliation[Yamout, Bassem] Harley St Med Ctr, Neurol Inst, Abu Dhabi, U Arab Emirates.-
local.description.affiliation[Zakaria, Magd] Ain Shams Univ, Dept Neurol, Cairo, Egypt.-
local.description.affiliation[Ziemssen, Tjalf] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Ctr Clin Neurosci, Dept Neurol, Dresden, Germany.-
local.uhasselt.internationalyes-
item.accessRightsClosed Access-
item.fullcitationAERTS, Sofie; GEYS, Lotte; SEVERIJNS, Deborah; Alkhawajah, Mona; Berger, Thomas; Boyko, Alexey; Grigoriadis, Nikolaos; Hartung, Hans-Peter; Magyari, Melinda; Oreja-Guevara, Celia; Pozzilli, Carlo; Vermersch, Patrick; Yamout, Bassem; Zakaria, Magd; Ziemssen, Tjalf; POPESCU, Veronica; PEETERS, Liesbet & VAN WIJMEERSCH, Bart (2026) Directions for advancing prognostic assessments in multiple sclerosis: Qualitative Insights from MS specialist Interviews. In: Journal of the neurological sciences, 481 (Art N° 125756).-
item.fulltextNo Fulltext-
item.contributorAERTS, Sofie-
item.contributorGEYS, Lotte-
item.contributorSEVERIJNS, Deborah-
item.contributorAlkhawajah, Mona-
item.contributorBerger, Thomas-
item.contributorBoyko, Alexey-
item.contributorGrigoriadis, Nikolaos-
item.contributorHartung, Hans-Peter-
item.contributorMagyari, Melinda-
item.contributorOreja-Guevara, Celia-
item.contributorPozzilli, Carlo-
item.contributorVermersch, Patrick-
item.contributorYamout, Bassem-
item.contributorZakaria, Magd-
item.contributorZiemssen, Tjalf-
item.contributorPOPESCU, Veronica-
item.contributorPEETERS, Liesbet-
item.contributorVAN WIJMEERSCH, Bart-
crisitem.journal.issn0022-510X-
crisitem.journal.eissn1878-5883-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.